Intraoperative Radiation Therapy Market Size, Share & Trends Analysis Report By Systems and Accelerators (Applicators & Afterloaders, Treatment Planning Systems, Accessories, Services), By Technology (Electron IORT, Intraoperative Brachytherapy), By Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head and Neck Cancer, Colorectal Cancer, Others), By End User (Hospitals, Specialty Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Intraoperative Radiation Therapy Market Size & Growth Analysis

The global intraoperative radiation therapy market size was valued at USD 129.01 million in 2025 and is projected to grow from USD 139.55 million in 2026 to USD 261.57 million by 2034, registering a CAGR of 8.17% during the forecast period from 2026 to 2034. North America dominated the intraoperative radiation therapy market with a market share of 42.64% in 2025.

The intraoperative radiation therapy market comprises specialized systems, applicators, treatment planning technologies, accessories, and service offerings designed to deliver targeted radiation during surgical procedures. It includes electron-based IORT and intraoperative brachytherapy solutions used across major cancer applications such as breast, brain, gastrointestinal, head and neck, and colorectal tumors. These technologies are adopted by hospitals, specialty oncology clinics, and other care facilities to enhance precision, reduce treatment cycles, and improve patient outcomes.

Products & Services Insights

The systems and accelerators segment dominated the market in 2025, accounting for 61.05% revenue share, owing to the rising demand for compact, low scatter electron accelerators engineered specifically for constrained hybrid operating rooms. These systems allow precise radiation delivery without major room shielding upgrades, making them highly attractive for infrastructure-limited surgical oncology programs.

The services segment is estimated to register the fastest CAGR of 8.76% during the forecast period. This growth is fuelled by the increasing demand for on-site dosimetry validation services tailored for intraoperative scenarios, where real-time calibration support ensures accurate dose delivery. Hospitals rely on specialized service teams to optimize treatment parameters during surgery, improving safety and clinical confidence.

Request Customizationto receive a tailored report.

Technology Insights

The electron IORT segment dominated the market and accounted for the highest revenue share in 2025. This growth is attributed to rising utilization of ultra-short electron beam pulses that minimize tissue scattering, enabling highly localized radiation during complex tumor resections. This precision appeals to surgeons seeking maximal tumor control with minimal collateral damage.

The intraoperative brachytherapy segment is projected to register the fastest CAGR of 8.93% during the forecast timeframe, owing to the development of customized, 3D printed applicators that conform precisely to patient-specific tumor cavities, enhancing radiation coverage and minimizing exposure to surrounding healthy tissues, thereby increasing procedural effectiveness and adoption in complex surgeries.

Application Insights

The breast cancer segment dominated the market, accounting for 42.31% of revenue share in 2025, owing to the preference for single-dose IORT during lumpectomy, reducing treatment duration, minimizing healthy tissue exposure, and improving cosmetic outcomes, driving higher adoption rates compared to other cancers.

The head and neck cancer segment is expected to register the fastest CAGR during the forecast period, owing to the increasing use of intraoperative brachytherapy combined with customized 3D printed oral cavity molds, enabling precise radiation delivery in anatomically complex regions and reducing damage to critical structures like salivary glands and nerves.

End User Insights

The hospitals segment dominated the market with a revenue share of 63.82% in 2025. This growth is driven by the integration of hybrid operating suites combining surgical and radiation capabilities, allowing hospitals to perform intraoperative radiation therapy seamlessly within existing infrastructure, enhancing workflow efficiency and attracting high patient volumes for advanced cancer treatments.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominated the intraoperative radiation therapy market in 2025, accounting for 42.64% market share. The growth is supported by the region’s concentration of leading academic cancer centers that actively conduct clinical trials and early adoption of advanced radiation technologies. This research-driven environment accelerates technology validation, encourages surgeon familiarity, and fosters widespread integration of IORT systems across top-tier hospitals.

In the U.S., the widespread adoption of compact and mobile intraoperative radiation systems in regional and community hospitals is expanding access beyond major cancer centers. This accessibility enables smaller hospitals across diverse geographies to offer advanced IORT treatments, notably broadening the patient base and accelerating market penetration.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

Asia Pacific is emerging as the fastest-growing region with a CAGR of 9.82% from 2026 to 2034. This growth is augmented by the emergence of regionally manufactured, cost-efficient, compact IORT systems. These devices allow smaller hospitals and cancer centers across urban and semi-urban areas to adopt advanced intraoperative radiation therapies, expanding patient access and accelerating regional market penetration.

Japan’s market growth is supported by the combination of robotic-assisted surgery with IORT. Japanese hospitals are increasingly integrating robotic surgery platforms with intraoperative radiation delivery, allowing ultra-precise tumor resection and radiation in complex anatomical areas; this synergy boosts demand for IORT systems nationwide.

Europe Market Insights

Europe’s intraoperative radiation therapy market is experiencing strong growth due to the harmonization of medical-device regulations under the European Medicines Agency (EMA), which accelerates approval processes across EU member states. This streamlined pathway reduces time-to-market and promotes wider adoption of advanced intraoperative radiation therapy systems.

Germany’s market growth is supported by its well-established network of academic university hospitals that run extensive clinical research and evidence gathering for IORT across multiple cancer types. These robust research clinical collaborations accelerate clinical validation of IORT techniques, boosting adoption among German oncology centers.

Latin America Market Insights

Latin America’s market is growing steadily due to increasing adoption of compact, low‑cost IORT devices in large urban cancer centers that lack traditional radiotherapy bunkers. These systems allow metropolitan hospitals in São Paulo, Rio de Janeiro, and Mexico City to implement IORT without major infrastructure, expanding access to advanced surgical radiation therapy.

Argentina's intraoperative radiation therapy market is expanding rapidly due to the establishment of a regional cancer care hub by Comisión Nacional de Energía Atómica (CNEA), designated as an IAEA Rays of Hope Anchor Centres, the only such hub in Latin America, which boosts local capacity building, training, and radiation infrastructure, fostering broader IORT adoption nationwide.

Middle East and Africa Market Insights

The Middle East and Africa market growth is propelled by the emergence of “pay‑per‑use” financing models for radiation therapy systems in low‑resource African countries. This approach, pioneered by collaborations such as MedAccess with Elekta, lowers upfront capital burdens, enabling underfunded hospitals to adopt IORT equipment without full purchase costs, thereby expanding access to advanced intraoperative radiotherapy across underserved regions.

South Africa's intraoperative radiation therapy market is witnessing growth driven by the expansion of advanced radiotherapy infrastructure in public hospitals, including modern LINAC and brachytherapy suites at Groote Schuur Hospital, enabling precise intraoperative radiation delivery and broader adoption without full-scale cancer center upgrades.

Competitive Landscape

The global intraoperative radiation therapy market is moderately fragmented, with leading medical device companies holding major shares. Market leaders sustain dominance through continuous product innovation, strategic collaborations, and expansion of service and distribution networks to enhance accessibility. Key players include Carl Zeiss Meditec AG, Elekta AB, Novacure, Xoft Inc., and Mobetron, among others, driving technological advancements and clinical adoption across hospitals and specialty oncology centers worldwide.

Xoft Inc.: An emerging market player

Xoft Inc., a U.S.-based medical technology company, is gaining prominence in the market with its electronic brachytherapy solutions. In 2023, Xoft expanded its adoption across oncology centers in North America and Europe through FDA-cleared devices and hospital partnerships. By offering portable, high precision IORT systems with streamlined clinical integration, Xoft is establishing itself as an emerging player in the market.

List of Key and Emerging Players in Intraoperative Radiation Therapy Market